Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-09-03

Clinical Trial Update: A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Endostar in combination with chemotherapy for osteosarcoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Endostar (recombinant human endostatin)

Snippet

Sponsor: Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | Conditions: Osteosarcoma | Phase 2 | Status: UNKNOWN